Sectors
INSP
Inspire Medical Systems, Inc.
42.72
1 x 43.09
1 x 43.34
bid
ask
+
0.06
0.15%
10:13 AM
timesize
| Ytd | -53.68% | |
| 1y | -71.46% |
42.51
day range
43.94
41.52
52 week range
153.07
| Open | 43.30 | Prev Close | 42.66 | Low | 42.51 | High | 43.94 | Mkt Cap | 1.23B |
| Vol | 100.63K | Avg Vol | 1.16M | EPS | 4.40 | P/E | 9.67 | Forward P/E | 31.79 |
| Beta | 0.83 | Short Ratio | 2.79 | Inst. Own | 119.95% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-03 | 50-d Avg | 53.75 | 200-d Avg | 79.51 | 1yr Est | 53.33 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2026-05-04 | 2026-03 | 0 | 0.1 | 0.46 | 127.78% |
| 2026-02-11 | 2025-12 | 0.69 | 1.65 | 0.96 | 139.13% |
| 2026-02-11 | 2025-12 | 0.69 | N/A | N/A | N/A |
| 2025-11-03 | 2025-09 | 0 | N/A | N/A | N/A |
| 2025-11-03 | 2025-09 | 0 | 0.38 | 0.53 | 353.33% |
| 2025-08-04 | 2025-06 | 0.22 | N/A | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2026-05-07 | Oppenheimer | Upgrade | Perform | Perform |
| 2026-05-05 | JP Morgan | Upgrade | Neutral | Neutral |
| 2026-05-05 | Piper Sandler | Downgrade | Overweight | Neutral |
| 2026-05-05 | Stifel | Upgrade | Buy | Buy |
| 2026-05-05 | RBC Capital | Upgrade | Sector Perform | Sector Perform |
| 2026-05-05 | Truist Securities | Upgrade | Hold | Hold |
Profile
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2025-08-28 | BUCHHOLZ RICHARD | Chief Financial Officer | 50.77K | Sale |
| 2026-02-19 | HERBERT TIMOTHY P | Chief Executive Officer | 163.49K | Stock Award(Grant) |
| 2026-02-19 | KELLY JASON P | Officer | 19.95K | Stock Award(Grant) |
| 2026-02-19 | MANN MELISSA | Officer | 23.61K | Stock Award(Grant) |
| 2026-05-07 | MCCORMICK SHAWN T | Director | 30.71K | Sale |
| 2026-04-29 | MEAD DANA G JR | Director | 26.21K | Stock Award(Grant) |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-03-30 | Blackrock Inc. | 3.55M | 151.57M | 12.32% |
| 2025-12-30 | Wellington Management Group, LLP | 2.21M | 94.41M | 7.67% |
| 2026-03-30 | Vanguard Portfolio Management LLC | 1.64M | 69.91M | 5.68% |
| 2025-12-30 | Deerfield Management Company, L.P | 1.51M | 64.30M | 5.23% |
| 2026-03-30 | Vanguard Capital Management LLC | 1.27M | 54.09M | 4.40% |
| 2025-12-30 | Morgan Stanley | 1.26M | 53.79M | 4.37% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-03-30 | iShares Trust-iShares Core S&P Small-Cap ETF | 1.56M | 66.66M | 5.42% |
| 2026-01-30 | VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1.09M | 46.71M | 3.80% |
| 2025-12-30 | VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 899.59K | 38.41M | 3.12% |
| 2026-01-30 | Vanguard Explorer Fund | 761.65K | 32.52M | 2.64% |
| 2025-12-30 | VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 658.80K | 28.13M | 2.29% |
| 2025-12-30 | Artisan Partners Funds Inc.-Artisan International Small-Mid Fund | 481.99K | 20.58M | 1.67% |
Dividend
| Dividend | Date |
|---|---|
| 9 | 2008-01-09 |
